《美股業績》達美航空(DAL.US)季績勝預期 料今年可錄得盈利
達美航空(DAL.US)第四季調整後每股盈利爲0.22美元,超過分析師平均預期的0.14美元,亦是連續第二個季度錄得盈利。
公司表示,新一波疫情爆發可能導致公司在1月及2月蝕錢,從而令首季出現虧損,但預計旅遊需求復甦會在2月下旬恢復,帶動公司在餘下季度扭虧爲盈,預計全年將錄得實質性的利潤,支持公司到2024年超過在疫情前定下的財務目標。
達美航空表示,目前海外預訂量有所下降,但當Omicron變種病毒引起的邊境限制取消,跨大西洋市場在春季及夏季的需求會非常強勁,預計商務旅遊需求亦會在2月中旬回升,而截至3月止季度收入將恢復到2019年水平的72%至76%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.